SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-03
👔
Nuo Therapeutics, Inc.
@AURX_InsiderForm 4 Filing: Mintz Paul Acquires (Grant) shares of $AURX
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Nuo Therapeutics, Inc.
Ticker: $AURX
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-29
Shares: 30,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Mintz Paul, holds the title of Director at Nuo Therapeutics, Inc..
On 2026-06-29, the insider transacted 30,000 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Mintz Paul (Director) was granted $0 of $AURX
Post-Transaction Position: 30,000 shares
SEC Accession No: 0001437749-26-022661 (CIK: 1480208)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.